Probiotic compositions and process thereof
Probiotic composition(s) and/or process(es) thereof. Processes may include applying Janthinobacterium , for example Janthinobacterium lividum , over a host and/or host area(s) to minimize microbe(s) and/or maximize therapeutic effects. A process to minimize a microbe may include applying to skin a composition including isolated Janthinobacterium lividum and a pharmaceutically acceptable carrier. Probiotic composition(s) and/or process(es) thereof may include relatively heat tolerant Janthinobacterium lividum which may produce metabolites, for example violacein up to approximately 29° C. Probiotic composition(s) and/or process(es) thereof may include Janthinobacterium lividum between approximately 25×10 6 and 6.4×10 7 cells. Probiotic composition(s) and/or process(es) thereof may include Janthinobacterium lividum which has and/or produces between approximately 18 μM and 129 μM of violacein. Probiotic composition(s) and/or process(es) thereof may include a stimulant to maximize metabolites. A process to minimize a microbe may include removing a portion of resident microbes with a sanitizer. Janthinobacterium lividum may be in lysed form.
1. A process to minimize a microbe colony growth comprising applying to human skin a composition including isolated Janthinobacterium lividum and a pharmaceutically acceptable carrier.
2. The process of claim 1 , wherein the skin is human foot skin.
3. The process of claim 1 , wherein said microbe comprises at least one of bacteria, yeast, fungus and virus.
4. The process of claim 3 , wherein said fungus comprises Tricophyton rubrum.
5. The process of claim 1 , wherein said Janthinobacterium lividum produces violacein up to approximately 29° C.
6. The process of claim 1 , wherein said Janthinobacterium lividum comprises between approximately 25×10 6 and 6.4×10 7 cells per ml of said pharmaceutically acceptable carrier.
7. The process of claim 6 , wherein said Janthinobacterium lividum produces between approximately 18 μM and 129 μM of violacein.
8. The process of claim 1 , wherein said pharmaceutically acceptable carrier comprises at least one of an emulsion, paste, cream, lotion, gel, jelly, ointment, oil, aerosol, powder and solvent.
9. The process of claim 1 , wherein said composition comprises a stimulant to maximize at least violacein.
10. The process of claim 9 , wherein said stimulant comprises tryptophan.
11. The process of claim 1 , comprising applying a sanitizer to said skin prior to applying said composition.
12. The process of claim 11 , wherein said sanitizer comprises hydrogen peroxide.
13. The process of claim 1 , wherein said Janthinobacterium lividum is in a lysed form.
14. A process to minimize Tricophyton rubrum colony growth comprising applying to skin a composition including isolated Janthinobacterium lividum and a pharmaceutically acceptable carrier.
15. A process to minimize a microbe colony growth comprising applying to skin a composition including isolated Janthinobacterium lividum , a stimulant to maximize at least violacein, and a pharmaceutically acceptable carrier.
16. A process to minimize a microbe colony growth comprising applying to skin a composition including isolated Janthinobacterium lividum and a pharmaceutically acceptable carrier, wherein said Janthinobacterium lividum is in a lysed form.